Have a read of the 8th June 2022 announcement of the first boy receiving treatment. It explains what happens.
Effectively after 24 weeks they transition into an open lable expansion trial receiving either a 25 or 50 dose of atl1102. Any placebo dosing would finish and be replaced.
6 months passed since first patient, page-3
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $50.98K | 508.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 69109 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 249627 | 5 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |